MVAL vs. CDC
MVAL (VanEck Morningstar Wide Moat Value ETF) and CDC (VictoryShares US EQ Income Enhanced Volatility Wtd ETF) are both Large Cap Value Equities funds - MVAL tracks the Morningstar US Broad Value Wide Moat Focus Index - Benchmark TR Gross while CDC tracks the Nasdaq Victory U.S. Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. Both are passively managed. Over the past year, MVAL returned 13.96% vs 18.16% for CDC. A 0.75 correlation means they provide meaningful diversification when combined. MVAL charges 0.49%/yr vs 0.37%/yr for CDC.
Performance
MVAL vs. CDC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MVAL achieves a -2.29% return, which is significantly lower than CDC's 10.57% return.
MVAL
- 1D
- -0.54%
- 1M
- -0.15%
- YTD
- -2.29%
- 6M
- -2.26%
- 1Y
- 13.96%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CDC
- 1D
- -0.57%
- 1M
- -0.39%
- YTD
- 10.57%
- 6M
- 10.29%
- 1Y
- 18.16%
- 3Y*
- 11.97%
- 5Y*
- 5.08%
- 10Y*
- 10.03%
MVAL vs. CDC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
MVAL VanEck Morningstar Wide Moat Value ETF | -2.29% | 14.17% | 6.10% |
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF | 10.57% | 8.96% | 7.99% |
Correlation
The correlation between MVAL and CDC is 0.69, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.69 |
Correlation (All Time) Calculated using the full available price history since Apr 1, 2024 | 0.75 |
The correlation between MVAL and CDC has been stable across timeframes, ranging from 0.69 to 0.75 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MVAL vs. CDC — Risk / Return Rank
MVAL
CDC
MVAL vs. CDC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Morningstar Wide Moat Value ETF (MVAL) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MVAL | CDC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.84 | ||
| Sortino ratioReturn per unit of downside risk | -1.19 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.32 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 1.15 | 3.22 | -2.07 |
| Martin ratioReturn relative to average drawdown | 2.87 | 11.37 | -8.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MVAL | CDC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.02 | 1.87 | -0.84 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.41 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.76 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.53 | 0.74 | -0.22 |
Drawdowns
MVAL vs. CDC - Drawdown Comparison
The maximum MVAL drawdown since its inception was -19.56%, smaller than the maximum CDC drawdown of -21.37%. Use the drawdown chart below to compare losses from any high point for MVAL and CDC.
Loading charts...
Drawdown Indicators
| MVAL | CDC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -19.56% | -21.37% | +1.81% |
Max Drawdown (1Y)Largest decline over 1 year | -12.16% | -5.67% | -6.49% |
Max Drawdown (3Y)Largest decline over 3 years | — | -12.70% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -21.37% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -21.37% | — |
Current DrawdownCurrent decline from peak | -10.57% | -2.20% | -8.37% |
Average DrawdownAverage peak-to-trough decline | -3.78% | -5.09% | +1.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.88% | 1.60% | +3.28% |
Volatility
MVAL vs. CDC - Volatility Comparison
VanEck Morningstar Wide Moat Value ETF (MVAL) has a higher volatility of 3.59% compared to VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) at 2.66%. This indicates that MVAL's price experiences larger fluctuations and is considered to be riskier than CDC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MVAL | CDC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.59% | 2.66% | +0.93% |
Volatility (6M)Calculated over the trailing 6-month period | 9.59% | 6.84% | +2.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 13.73% | 9.77% | +3.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.40% | 12.54% | +2.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.40% | 13.21% | +2.19% |
MVAL vs. CDC - Expense Ratio Comparison
MVAL has a 0.49% expense ratio, which is higher than CDC's 0.37% expense ratio.
Dividends
MVAL vs. CDC - Dividend Comparison
MVAL's dividend yield for the trailing twelve months is around 1.79%, less than CDC's 3.18% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF | 3.18% | 3.36% | 3.32% | 4.24% | 3.48% | 2.65% | 2.48% | 3.04% | 3.37% | 2.81% | 2.99% | 3.17% |
MVAL VanEck Morningstar Wide Moat Value ETF | 1.79% | 1.75% | 0.97% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
MVAL and CDC have a correlation of 0.69, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MVAL has higher volatility (3.59%) compared to CDC (2.66%). In terms of maximum drawdown, MVAL dropped -19.56% vs CDC's -21.37%.
On 1-year performance, CDC leads with 18.16% vs 13.96% for MVAL. On fees, CDC is cheaper at 0.37% per year. On volatility, CDC has been the lower-risk option at 2.66%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, CDC has performed better with a 18.16% return vs 13.96%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
CDC is cheaper with a 0.37% expense ratio, compared with 0.49% for MVAL.
CDC has the higher dividend yield at 3.18%, compared with 1.79% for MVAL.
MVAL tracks Morningstar US Broad Value Wide Moat Focus Index - Benchmark TR Gross, while CDC tracks Nasdaq Victory U.S. Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. They also come from different issuers: VanEck and Crestview. Their fees differ too: 0.49% for MVAL and 0.37% for CDC.
CDC currently has the higher Sharpe Ratio (1.87 vs 1.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MVAL and CDC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer